Flagstar Bank NA vs Revolution Medicines Inc. Common Stock — how do they compare? Flagstar Bank NA trades at $11.36 (market cap $4.71B), while Revolution Medicines Inc. Common Stock trades at $189.1 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 8.6× Flagstar Bank NA's market cap, and Flagstar Bank NA pays a 0.35% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flagstar Bank NA for 21 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FLG | RVMD | |
|---|---|---|
Market Cap | $4.71B | $40.32B |
Volume | 7,410,589 | 4,855,734 |
Sector | Financials | Health |
52-Week High | $15.36 | $221.15 |
52-Week Low | $10.72 | $47.50 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $15.25B | $37.02B |
Dividend Yield | 0.35% | — |
Signals from Pluang's Aura AI — not financial advice
Flagstar Bank (FLG) trades at $11.30, down 2.25% on the day, with a bearish technical outlook despite recent earnings beats. The company shows improving fundamentals with Q2 2026 marking the third consecutive profitable quarter, though it missed EPS estimates. Analyst sentiment remains positive with a $17.07 consensus price target representing 51% upside potential. Recent strategic developments include a $250 million share repurchase program and a new core banking partnership with Fiserv.
The stock presents a compelling value opportunity trading at 0.62x book value, but faces risks from volatile earnings performance and negative cash flow trends. While analyst consensus is bullish with 60% buy ratings, investors should monitor execution on profitability improvements and the impact of recent strategic initiatives on long-term growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →